Home Data Calendar Blog

WVE

Tables

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2015-03-31
Common Stock Value 935.37841.40839.67837.89802.83802.70802.45751.23749.85716.12707.71694.09694.07551.54540.16539.55538.79538.54538.41375.15374.50373.15311.59310.04309.43309.36215.81215.60215.50215.37185.3422.45NANA
Earnings Per Share Basic -0.150.07-0.20-0.27-0.45-0.42-0.62-0.62-0.61-0.12-0.78NANANANANANANANANANANANANANANANANANANANANANANA
Earnings Per Share Diluted -0.150.07-0.20-0.27-0.45-0.42-0.62-0.62-0.61-0.12-0.78NANANANANANANANANANANANANANANANANANANANANANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2015-03-31
Revenue From Contract With Customer Excluding Assessed Tax 29.0649.2122.1112.931.240.280.381.751.7636.422.789.443.453.034.162.402.937.633.033.624.494.881.421.101.311.100.380.680.390.420.000.000.130.03
Revenues 29.0649.2122.1112.931.240.280.381.751.7636.422.789.443.453.034.162.402.937.633.033.624.494.881.421.680.680.680.680.680.390.420.000.000.130.03
Operating Expenses 47.7444.7745.5843.2144.8039.1842.5439.8437.8844.0342.6039.7537.8741.6854.1562.9357.1153.2451.0152.5642.7341.4537.2032.2627.6725.7720.5919.1817.6212.057.214.993.753.49
Research And Development Expense 34.0731.6433.3130.9831.0827.5729.7327.4725.7631.0931.6430.0328.2731.4841.1649.1344.5941.6040.1139.8132.8832.5529.2025.3720.1019.1014.7413.9913.698.403.472.131.851.61
General And Administrative Expense 13.6613.1312.2712.2313.7211.6112.8112.3712.1112.9410.979.729.5910.2113.0013.8012.5211.6410.9012.759.858.908.006.897.576.675.855.183.943.653.752.861.911.88
Operating Income Loss -18.684.44-23.47-30.29-43.56-38.90-42.16-38.09-36.11-7.61-39.83-30.31-34.41-38.66-49.99-60.53-54.18-45.62-47.99-48.94-38.23-36.57-35.77-30.58-26.99-25.09-19.91-18.50-17.23-11.64-7.21-4.99-3.63-3.46
Allocated Share Based Compensation Expense 2.352.282.412.752.913.376.953.973.735.902.723.223.283.794.004.995.025.164.344.013.613.544.433.183.002.973.002.532.181.270.810.720.651.85
Income Tax Expense Benefit 0.00-0.68NANANANANANANANANANANA0.000.000.000.000.000.00-0.100.000.000.17-0.20-0.420.021.300.190.380.05-0.140.080.050.05
Profit Loss -16.267.25-21.10-27.41-43.71-39.00-41.30-37.81-34.78-6.23-38.77-28.79-33.10-40.53-47.49-56.77-50.73-41.94-44.20-37.89-37.63-35.89-35.24-30.79-25.49NANANANANANANANANA
Net Income Loss -16.267.25-21.10-27.41-43.71-39.00-41.30-37.81-34.78-6.23-38.77-28.79-33.10-40.53-47.49-56.77-50.73-41.94-44.20-37.89-37.63-35.89-35.24-30.21-26.14-24.69-21.00-18.45-17.54-11.56-7.10-4.94-3.70-3.46
Comprehensive Income Net Of Tax -16.207.22-21.20-27.43-43.62-39.08-41.44-37.90-34.86-6.24-38.77-28.70-33.08-40.52-47.49-56.78-50.72-41.91-44.10-37.91-37.65-35.86-35.19-29.82-26.13-24.69-20.98-18.83-17.53-11.54-7.10-4.93-3.69-3.49

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2015-03-31
Assets 274.95199.92229.99267.27146.39181.51213.32167.36207.01200.51206.41279.24310.06203.95238.57284.25347.21385.55430.61295.94324.58353.74150.42181.84202.09226.43151.51164.81179.97190.34165.4271.00NANA
Liabilities 227.44232.53273.83294.11183.60178.16174.50159.54166.63162.74176.69188.59193.95200.57209.84212.64224.56217.45225.88214.72210.10206.5732.5034.1628.3629.6526.5522.0720.9616.194.063.60NANA
Liabilities And Stockholders Equity 274.95199.92229.99267.27146.39181.51213.32167.36207.01200.51206.41279.24310.06203.95238.57284.25347.21385.55430.61295.94324.58353.74150.42181.84202.09226.43151.51164.81179.97190.34165.4271.00NANA
Stockholders Equity 39.63-40.49-51.72-34.71-45.09-4.5230.95-0.0532.5029.9021.8482.78108.24-4.4920.8663.73114.77160.22196.8673.35106.61139.30110.05139.81165.86188.91117.09134.86151.13166.28153.49-3.12NANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2015-03-31
Assets Current 235.37158.57184.71219.5998.54131.43160.11124.38162.56157.99159.43230.04258.43146.83149.79185.48250.26289.59315.03202.27233.16267.67117.96150.49173.83201.22132.78151.99172.14183.94161.3867.99NANA
Cash And Cash Equivalents At Carrying Value 200.35139.94172.97207.5688.5096.95123.1661.71150.56123.90143.84184.50216.3694.05120.95147.16209.01252.91287.57174.82210.49241.43110.49142.50168.46197.39129.48150.29169.01181.76161.2266.047.7810.96
Accounts Receivable Net Current 21.097.00NANANANANANANA22.50NA30.0030.0030.00NA20.0020.0020.0010.0010.0010.0015.00NA1.00NANANANANANANANANANA
Other Assets Current 4.024.122.722.802.112.026.555.735.423.966.405.114.1016.3318.848.69NANANA10.87NANANANANANANANANANANANANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2015-03-31
Assets Noncurrent 39.5841.3545.2847.6847.8550.0853.2042.9844.4442.5246.9849.2051.6357.1288.7898.7796.9595.96115.5893.6791.4286.0732.4631.36NANANA12.82NANANANANANA
Property Plant And Equipment Gross 55.79NANANA55.13NANANA54.50NANA54.09NANANA53.37NANANA49.43NANANA31.75NANANA11.10NANA4.403.72NANA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 42.7141.6040.4239.2037.85NANANA32.23NANA24.89NANANA17.00NANANA9.50NANANA4.42NANANA2.49NANA1.611.77NANA
Property Plant And Equipment Net 13.0813.7714.9816.0017.2818.5519.8121.0522.2724.0225.8429.2031.1233.1034.9936.3737.2038.3639.9339.9337.7232.3828.7827.3324.5820.7714.308.616.695.092.791.95NANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2015-03-31
Liabilities Current 186.4499.98140.23132.5771.5264.2664.0858.4964.2031.6446.72121.04109.66110.45118.88118.15133.41124.08131.88130.04125.8043.7816.3019.6215.1215.5514.0712.1511.438.653.823.47NANA
Accounts Payable Current 12.8412.6112.3811.9116.9115.9311.179.857.287.448.6513.799.7013.9116.499.0720.2211.4614.5813.0911.967.158.017.604.717.987.404.943.833.902.812.88NANA
Accrued Liabilities Current 1.773.082.662.133.521.913.473.153.573.383.232.142.20NANA5.03NANANA5.50NANANA3.28NANANANANANANANANANA
Contract With Customer Liability Current 150.0668.25111.13106.9631.5632.3437.4736.4337.108.7424.1891.5686.1984.8588.0489.6596.3297.96105.89100.94103.2327.29NA1.27NANANANANANANANANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2015-03-31
Liabilities Noncurrent 41.01132.55133.60161.54112.08113.90110.42101.05102.43131.10129.9767.5584.2890.1190.9694.4991.1593.3694.0084.6884.30162.7916.2014.5313.2314.0912.489.929.547.540.240.12NANA
Operating Lease Liability Noncurrent 25.4027.1728.8830.5332.1233.6735.1623.6224.9522.4823.5525.5926.5727.5128.4329.30NANANANANANANANANANANANANANANANANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2015-03-31
Stockholders Equity 39.63-40.49-51.72-34.71-45.09-4.5230.95-0.0532.5029.9021.8482.78108.24-4.4920.8663.73114.77160.22196.8673.35106.61139.30110.05139.81165.86188.91117.09134.86151.13166.28153.49-3.12NANA
Common Stock Value 935.37841.40839.67837.89802.83802.70802.45751.23749.85716.12707.71694.09694.07551.54540.16539.55538.79538.54538.41375.15374.50373.15311.59310.04309.43309.36215.81215.60215.50215.37185.3422.45NANA
Additional Paid In Capital 129.24126.89124.60122.19119.44116.53113.1791.9587.9884.2578.3671.5768.3565.0761.2857.2852.2947.2742.1137.7733.7630.1526.6022.1719.0016.0013.0310.037.575.323.18NANANA
Retained Earnings Accumulated Deficit -1024.85-1008.59-1015.85-994.74-967.34-923.63-884.62-843.33-805.51-770.73-764.50-683.27-654.48-621.38-580.85-533.36-476.59-425.86-383.92-339.72-301.83-264.20-228.31-192.51-162.30-136.17-111.47-90.48-72.02-54.49-35.08-27.98NANA
Accumulated Other Comprehensive Income Loss Net Of Tax -0.12-0.18-0.15-0.05-0.03-0.12-0.050.100.180.260.270.390.300.280.270.270.280.280.250.150.180.200.170.12-0.27-0.27-0.28-0.290.080.080.040.04NANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2015-03-31
Net Cash Provided By Used In Operating Activities -33.24-34.46-37.2685.52-33.44-25.65-28.82-39.87-7.03-28.18-9.40-31.41-20.17-38.15-26.25-61.24-43.68-32.93-50.38-32.82-29.0171.39-32.43-22.75-23.41NANANANANANANANANA
Net Cash Provided By Used In Investing Activities -0.36-0.20-0.07-0.4924.84-0.5024.61-50.21-0.01-0.10-0.34-0.56-0.07-0.14-0.58-1.35-0.47-1.60-0.51-3.46-3.39-1.92-1.16-4.08-5.61NANANANANANANANANA
Net Cash Provided By Used In Financing Activities 93.961.671.8535.050.060.0265.801.3233.798.355.040.02142.5211.380.610.760.25-0.16163.550.651.3561.561.540.590.06NANANANANANANANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2015-03-31
Net Cash Provided By Used In Operating Activities -33.24-34.46-37.2685.52-33.44-25.65-28.82-39.87-7.03-28.18-9.40-31.41-20.17-38.15-26.25-61.24-43.68-32.93-50.38-32.82-29.0171.39-32.43-22.75-23.41NANANANANANANANANA
Net Income Loss -16.267.25-21.10-27.41-43.71-39.00-41.30-37.81-34.78-6.23-38.77-28.79-33.10-40.53-47.49-56.77-50.73-41.94-44.20-37.89-37.63-35.89-35.24-30.21-26.14-24.69-21.00-18.45-17.54-11.56-7.10-4.94-3.70-3.46
Profit Loss -16.267.25-21.10-27.41-43.71-39.00-41.30-37.81-34.78-6.23-38.77-28.79-33.10-40.53-47.49-56.77-50.73-41.94-44.20-37.89-37.63-35.89-35.24-30.79-25.49NANANANANANANANANA
Increase Decrease In Accounts Receivable 14.09NANANANANANANA-22.5022.50NA0.000.000.00-20.000.000.00NANA0.00-5.00NANANANANANANANANA0.00NANANA
Increase Decrease In Accounts Payable 0.190.500.22-4.671.015.070.772.49-0.23-1.08-4.794.55-4.20-2.577.34-10.978.43-1.740.782.133.11-0.700.393.27-1.060.671.021.470.721.48-0.820.751.460.25

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2015-03-31
Net Cash Provided By Used In Investing Activities -0.36-0.20-0.07-0.4924.84-0.5024.61-50.21-0.01-0.10-0.34-0.56-0.07-0.14-0.58-1.35-0.47-1.60-0.51-3.46-3.39-1.92-1.16-4.08-5.61NANANANANANANANANA
Payments To Acquire Property Plant And Equipment 0.360.200.070.490.200.460.490.210.010.100.340.560.070.140.581.350.471.600.513.463.391.921.164.085.615.573.632.731.270.880.970.510.360.02

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2015-03-31
Net Cash Provided By Used In Financing Activities 93.961.671.8535.050.060.0265.801.3233.798.355.040.02142.5211.380.610.760.25-0.16163.550.651.3561.561.540.590.06NANANANANANANANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2015-03-31
Revenues 29.0649.2122.1112.931.240.280.381.751.7636.422.789.443.453.034.162.402.937.633.033.624.494.881.421.680.680.680.680.680.390.420.000.000.130.03
Revenue From Contract With Customer Excluding Assessed Tax 29.0649.2122.1112.931.240.280.381.751.7636.422.789.443.453.034.162.402.937.633.033.624.494.881.421.101.311.100.380.680.390.420.000.000.130.03
Takeda Pharmaceutical Company Limited, Category One Programs, Collaboration And License Agreement 10.1034.901.300.701.300.200.301.601.7036.402.809.503.40NANANANANANANANANANANANANANANANANANANANANA
Gsk Collaboration Agreement 18.9014.3020.8012.30NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Operating Income Loss
Expenses
Income Tax Expense Benefit
Balance Sheet
Operating Lease Right Of Use Asset
Assets
Other Assets
Current Assets
Other Assets Current
NonCurrent Assets
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
Property Plant And Equipment Net
Liabilities
Operating Lease Liability
Current Liabilities
Accrued Liabilities Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Other Nonoperating Income Expense
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Undiscounted Excess Amount

Line plots across dimensions of each concept